PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [L3-D6]
Usd: 350 Special Discount
Specification
Catalog# EM1701-62
PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [L3-D6]
-
WB
-
IHC-P
-
IF-Cell
-
IF-Tissue
-
Human
-
Mouse
-
Rat
-
unconjugated
Safety datasheet
Overview
Product Name
PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [L3-D6]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Recombinant protein within Human PI3-kinase p85 subunit alpha aa 19-219 / 724.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IHC-P, IF-Cell, IF-Tissue
Molecular Weight
Predicted band size: 84 kDa
Positive Control
MCF7 cell lysate, NIH/3T3 cell lysate, RAW264.7 cell lysate, Mouse brain tissue lysate, Rat liver tissue lysate, Raji cell lysate, C6 cell lysate, HepG2, LOVO, human brain tissue, human lung tissue, mouse lung tissue, rat lung tissue.
Conjugation
unconjugated
Clone Number
L3-D6
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein G affinity purified.
Application Dilution
-
WB
-
1:500-1:2,000
-
IF-Cell
-
1:50-1:200
-
IHC-P
-
1:50-1:1,000
-
IF-Tissue
-
1:200
Target
Function
Phosphatidylinositol 3-kinase (PI 3-kinase) is composed of p85 and p110 subunits. p85 lacks PI 3-kinase activity and acts as an adapter, coupling p110 to activated protein tyrosine kinase. Two forms of p85 have been described (p85α and p85β), each possessing one SH3 and two SH2 domains. Various p110 isoforms have been identified. p110α and p110β interact with p85α, and p110α has also been shown to interact with p85β in vitro. p110δ expression is restricted to white blood cells. It has been shown to bind p85α and β, but it apparently does not phosphorylate these subunits. p110δ seems to have the capacity to autophosphorylate. p110γ does not interact with the p85 subunits. It has been shown to be activated by α and βγ heterotrimeric G proteins.
Background References
1. Vainikka S et al. Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J Biol Chem 269:18320-18326 (1994).
2. Winnay J N et al. A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response. Nat Med 16:438-445 (2010).
Sequence Similarity
Belongs to the PI3K p85 subunit family.
Tissue Specificity
Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).
Post-translational Modification
Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation.; Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear (By similarity). Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.
Subcellular Location
Cytosol. Endoplasmic reticulum. Golgi apparatus. Nucleus. Plasma Membrane.
Synonyms
GRB1 antibody
p85 alpha antibody
p85 antibody
P85A_HUMAN antibody
Phosphatidylinositol 3 kinase associated p 85 alpha antibody
Phosphatidylinositol 3 kinase regulatory 1 antibody
Phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 1 (p85 alpha) antibody
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha antibody
Phosphatidylinositol 3-kinase regulatory subunit alpha antibody
Phosphoinositide 3 kinase, regulatory subunit 1 (alpha) antibody
ExpandGRB1 antibody
p85 alpha antibody
p85 antibody
P85A_HUMAN antibody
Phosphatidylinositol 3 kinase associated p 85 alpha antibody
Phosphatidylinositol 3 kinase regulatory 1 antibody
Phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 1 (p85 alpha) antibody
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha antibody
Phosphatidylinositol 3-kinase regulatory subunit alpha antibody
Phosphoinositide 3 kinase, regulatory subunit 1 (alpha) antibody
PI3 kinase p85 subunit alpha antibody
PI3-kinase regulatory subunit alpha antibody
PI3-kinase subunit p85-alpha antibody
PI3K antibody
PI3K regulatory subunit alpha antibody
Pik3r1 antibody
PtdIns 3 kinase p85 alpha antibody
PtdIns-3-kinase regulatory subunit alpha antibody
PtdIns-3-kinase regulatory subunit p85-alpha antibody
CollapseImages
-
Western blot analysis of PI 3 Kinase p85 alpha on different lysates with Mouse anti-PI 3 Kinase p85 alpha antibody (EM1701-62) at 1/1,000 dilution.
Lane 1: MCF7 cell lysate (20 µg/Lane)
Lane 2: NIH/3T3 cell lysate (20 µg/Lane)
Lane 3: RAW264.7 cell lysate (20 µg/Lane)
Lane 4: Mouse brain tissue lysate (40 µg/Lane)
Lane 5: Rat liver tissue lysate (40 µg/Lane)
Predicted band size: 84 kDa
Observed band size: 84 kDa
Exposure time: 3 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (EM1701-62) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of PI 3 Kinase p85 alpha on different lysates with Mouse anti-PI 3 Kinase p85 alpha antibody (EM1701-62) at 1/1,000 dilution.
Lane 1: Raji cell lysate
Lane 2: NIH/3T3 cell lysate
Lane 3: C6 cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 84 kDa
Observed band size: 84 kDa
Exposure time: 2 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (EM1701-62) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of PI 3 Kinase p85 alpha on different lysates with Mouse anti-PI 3 Kinase p85 alpha antibody (EM1701-62) at 1/1,000 dilution.
Lane 1: A549-si NT cell lysate
Lane 2: A549-si PI 3 Kinase p85 alpha cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 84 kDa
Observed band size: 84 kDa
Exposure time: 3 minutes; ECL: K1802;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (EM1701-62) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
ICC staining PI 3 Kinase p85 alpha (green) in HepG2 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
-
ICC staining PI 3 Kinase p85 alpha (green) in LOVO cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
-
Immunohistochemical analysis of paraffin-embedded human brain tissue with Mouse anti-PI 3 Kinase p85 alpha antibody (EM1701-62) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM1701-62) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human lung tissue with Mouse anti-PI 3 Kinase p85 alpha antibody (EM1701-62) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM1701-62) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse lung tissue with Mouse anti-PI 3 Kinase p85 alpha antibody (EM1701-62) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM1701-62) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat lung tissue with Mouse anti-PI 3 Kinase p85 alpha antibody (EM1701-62) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM1701-62) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Spatiotemporally Controllable In Situ Hydrogels Enabled by Nanobottle-Mediated Encapsulation Technology for Stage-Specific Synergistic Therapy of Osteoarthritis
Journal: Advanced Functional Materials
DOI: 10.1002/adfm.202531767
IF: 19
Application: WB
Reactivity: Rat
Publish date: 2026 Feb
-
Jujuboside B from Zizyphi spinosi semen inhibits hepatocellular carcinoma progression by targeting the PI3K/Akt signaling pathway in vitro and in vivo
Journal: Journal of Agriculture and Food Research
DOI: 10.1016/j.jafr.2026.102755
IF: 6.2
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
Bifidobacterium longum subsp. longum B-53 Alleviated Abnormalities of Glycolipid Metabolism and Oxidative Stress in T2DM Mice Through Regulating Gut Microbiota and GLP-1 Secretion
Journal: Journal Of Agricultural And Food Chemistry
DOI: 10.1021/acs.jafc.5c07346
IF: 6.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Conjugating 10,11-Dimethoxy-camptothecin with an Integrin αvβ3-Targeting Peptide through a Triazine Linker for Targeted Tumor Treatment in Lung and Pancreatic Carcinoma
Journal: Journal Of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.5c02059
IF: 6.8
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
1,2,3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation
Journal: Bioorganic Chemistry
DOI: 10.1016/j.bioorg.2025.109210
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Transcriptomics sequencing reveals Qu-shi-yu-fa Decoction promotes hair cycle and keratinization by upregulating FOXN1 and TGM3 to treat androgenetic alopecia
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2025.156837
IF: 8.3
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
Resveratrol Promotes Wound Healing by Enhancing Angiogenesis via Inhibition of Ferroptosis
Journal: Food Science & Nutrition
DOI: 10.1002/fsn3.70254
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2025 May
-
POLR2H Serves as a Novel Prognostic Biomarker Correlated with Immune Infiltration in Prostate Cancer
Journal: Biochemical Genetics
DOI: 10.1007/s10528-025-11150-y
IF: 1.6
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Exosomal SPRY4 from adipogenic BMSCs impairs angiogenesis via the PTPRB/TIE2/PI3K axis in Steroid-induced osteonecrosis of the femoral head
Journal: Stem Cell Research & Therapy
DOI: 10.1186/s13287-025-04505-0
IF: 7.3
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
ACAT1 inhibitor Avasimibe suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via CKB/PI3K-AKT signaling
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115973
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Dec
-
F127-CHO/Gelatin-NH₂ hydrogel delivering liposomal eriodictyol suppresses ferroptosis and attenuates retinal ganglion cell loss
Journal: International Journal Of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2025.149606
IF: 8.5
Application: WB
Reactivity: Rat
Publish date: 2025 Dec
-
Xanthoceras sorbifolium leaves alleviate hyperuricemic nephropathy by inhibiting the PI3K/AKT signaling pathway to regulate uric acid transport
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2024.117946
IF: 4.8
Application:
Reactivity:
Publish date: 2024 Mar
-
PI3K/Akt signalling pathway-associated long noncoding RNA signature predicts the prognosis of laryngeal cancer patients
Journal: Scientific Reports
DOI:
IF: 4.6
Application: WB
Reactivity: Human
Publish date: 2023 Sept
-
Caizhixuan hair tonic regulates both apoptosis and the PI3K/Akt pathway to treat androgenetic alopecia
Journal: Public Library Of Science One
DOI:
IF: 3.752
Application: WB
Reactivity: Mouse
Publish date: 2023 Feb
-
Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer
Journal: Biomed Research International
DOI:
IF: 3.411
Application: WB,IHC-P
Reactivity: Human
Publish date: 2022 Mar
-
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid
Journal: Nature Communications
DOI:
IF: 14.913
Application: WB
Reactivity: Human
Publish date: 2021 Sep
Alternative Products
Products with the same target and pathway
PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [A3-D0]
Application: WB,IF-Cell
Reactivity: Human
Conjugate: unconjugated
PI 3 Kinase p85 alpha Recombinant Rabbit Monoclonal Antibody [SU04-07]
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
PI 3 Kinase p85 alpha Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated